chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At approximately 4:30pm, on the day I got the vaccine, I began to feel the effects of Encephalopathy and Encephalitis, in which I began to feel pressure in my skull, and felt confusional thinking. It became hard to discern my thoughts. I also, began to experience a difficult time with my vision not being able to control what my vision was focusing on, as well as seeing a blue tint in my vision. I am also experiencing mild pressure and aches on the right side of my back and left side of my chest. These effects have been continuous for the last 4 days. To treat these symptoms I have been using natural remedies, and have maintained a stable condition due to that.
Extreme fatigue about 1 hour after shot.  Laid down to take a nap.  Woke up with a migraine headache, body aches/tightness all over, sore arm that was also itchy at injection site, lack of appetite and dizziness on and off.  I took 500 mg. tylenol and 800 mg.  ibuprofen for the headache and bodyaches at different times.  The ibuprofen made the body aches more tolerable and lessened the headache, but did not take them away.  Fatigue was constant and only lessened on fourth day.  Appetite resumed on third day, itchy arm stopped on fourth day.
She now has a wart on her thumb and I just saw another one between her fingers.  I'm not sure if the vaccine was the cause or if its just a coincidence....I've taken her to the Dr and they are now checking to see if the insurance will cover freezing it.
pneumonia; A spontaneous report was received from consumer, who is 76-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pneumonia.  The patient's medical history was not provided. No relevant Concomitant medications were reported.  On 20-FEB-2021, prior to the onset of the events, the patient received their first dose of mRNA-1273 (Lot number: 025J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 15-mar-2021 the patient was diagnosed with pneumonia by primary physician. The event is considered as medically significant.  Treatment medication included Levaquin.  Action taken with mRNA-1273 in response to the events was unknown   The event pneumonia was not recovered .; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, patient's advance age may remain a risk factor. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, patient's advance age may remain a risk factor. Further information has been requested.
I had been exposed by a friend after singing with them on May 11th. I had a minor change in taste, low grade fever of 99, chills that lasted a couple of days. I then developed a cough and had oxygen saturation issues. After two weeks, I started feeling a little better and went to see my primary doctor. He wasn't concerned about my oxygen levels. It continued to get worse. About a week ago I scheduled another appointment with a different doctor who did a chest x-ray and a CT scan because they were scared I could have a blood clot in my lungs. I did not. I had pneumonia. They put me on a 5 day antibiotic. I am not on a 12 day Prednisone protocol and Albuterol.
Covid arm. About 10 days after injection, red circle appeared around injection side with some raised parts. So far it is not painful or itchy
It was reported that a pt received a Fluzone SV 2000-2001 vaccination on 10/26/2000. Reportedly the pt developed a local reaction within 24 hours of vaccination consisting of injection site warmth, redness and bruise. Further information is requested.
This spontaneous report was received from a medical refers to an unspecified number of patients of unknown age and gender. No concurrent condition or medical history was reported. On an unknown date the patient was vaccinated with improperly stored GARDASIL 9 (lot # L007560, exp. 15-JUN-2017, dose and route of administration not provided) (Incorrect product storage). No concomitant therapy was reported. No symptoms were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the several reports from the same reporter. Additional information has been requested.
This spontaneous report as received from a medical assistant referring to five patients of unknown age and gender. On an unknown date, the patients were vaccinated with M-M-R II lot # M039913, expiration date 26-SEP-2018 for prophylaxis, reconstituted with sterile diluent (manufacturer unknown).  On an unspecified date, the vaccines and sterile diluent (manufacturer unknown) were exposed to temperature ranges between 47° Fahrenheit (F) to 77°F during a time frame of 12 hours 30 minutes. There was not previous temperature excursion. The temperature excursion was not called by a data logger. Adverse effects were not reported. Follow up information has been received from a medical assistant on 29-AUG-2017. He reported that on 10-JUL-2017, the patient was administered with an improperly stored dose of M-M-R II.; Sender's Comments: US-009507513-1708USA013498: US-009507513-1707USA004550:
This case meets criteria for vaccine breakthrough review. SxS include sore throat, cough, SOB, body aches, fatigue, mild abdominal pain.
Pt developed small blistering sore on/near lip. Pt had never had anything like this before. Sore did not resolve on it's own so after around 10 days pt began using Abreva. Began to clear - blisters started to go away. Pt stopped TX and reports that while not fully resolved, blisters are gone though some discoloration remains.
No adverse effect reported; 1 dose of improperly stored VARIVAX that underwent temperature excursion was administered to patient on 11/24/2018; Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported.  On 24-NOV-2018, the patient was vaccinated with 1 dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (0.5ml, subcutaneously, for prophylaxis; lot#N034551, expiration date was 05-DEC-2019) that underwent temperature excursion (improper storage of product in use), varicella virus vaccine live (oka/merck) (VARIVAX) was stored under the temperature ranging from minus 10 degrees celsius to 8 degrees celsius (minus 8.1 degrees celsius) for 37 minutes. It was unspecified whether administration occurred before the first temperature excursion or after the first one. It was unspecified how was concomitant therapy sterile diluent stored. Previous temperature excursion: minus 10  degrees celsius to 8 degrees celsius (minus 8.0 degrees celsius) for 2 hours. Data logger was involved. No adverse effects were reported. No product quality complaint (PQC).
Pt had arm pain since injection, pt states pain isn't as constant but still has significant pain with any pressure on the arm - ie if he bumps it, also can't sleep on that arm. Advised pt to follow-up with his primary care provider.
Patient received 2nd dose too early. Contacted guardian and recommended getting true 2nd dose now.
Pain on hip and leg started on 5/12 and continued on 5/13. 5/18 broke out with hives. 5/18 had doctor visit and visually confirmed with shingles. For shingles prescribed Acyclovir 200 mg and for nerve ending and pain Gabapentin and antibiotic Cephalexin 500 mg 3x/day. Improvement is not enough yet that is noticeable.
no known adverse events.  patient received wrong dose.  father wrote on consent form patient was 3 years old - patient given. 0.5mL.  Patient DOB reveals patient was 2 years old and correct dose for that age should have been 0.25 mL.  Calls to family have gone unanswered/unreturned to check on status of patient.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 20-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Onset chills, headache, malaise, heart racing continued through the night with resolving symptoms in the morning.
05/12/2003. Broke out in rash. Was seen in office 05/13/2002. Had about 15 lesions . Was diagnosed as chicken pox. Itchy, no fever. Had various temp.
This spontaneous report as received from a pharmacist refers to an approximately 80 year old male patient. The patient's medical history and drug allergies were not specified by the reporter. On 06-MAR-2015, the patient was vaccinated with a dose of ZOSTAVAX (19400 PFU (Plaque-Forming Unit(s)), lot# reported as K020186, expiration date January 2016, dose and route of administration were not reported). The patient's concomitant medication was not specified by the reporter. Approximately in 2015, the patient experienced pain on the backside of his arm and the side of his chest. No treatment was given for the adverse events. The patient sought medical attention by speaking with the pharmacist. The outcome of the pain on the backside of the arm and the side of the chest was reported as not recovered. Causality assessment between the pain on the backside of the arm and the side of his chest and the therapy with ZOSTAVAX was not provided. Product quality complaint (PQC) was not involved. Additional information has been requested.
Quarter sized erythema, warmth, tenderness - rapid progression over one hour from initial small red papule.
Complaints ongoing continuous pain and intermittent tingling at (R) deltoid injection site, radiating down to fingertips when performing daily routines. Incident not reported until 2/7/13. Denies being seen at ER for treatment.
Swelling, rash, warmth from knee to groin in (R) leg (injection site) ORAPRED 5 ml PO BID.
Breakthrough case admission after 4 vaccines Pfizer 2/10/21 Lot# El9267;  Pfizer 3/5/21 Lot# EN6202;  Pfizer 10/17/21 Lot# FH8020;  Pfizer 5/22/22 Lot# FJ4991
Dizziness, fever (100 degrees), malaise, stiff back and arm, headache especially through the eyes, lack of appetite.
COVID-19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Nov2021 as dose 2 (booster), single (Lot number: 3302680) at the age of 62 years, in left arm for covid-19 immunisation; janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), on 01Apr2021 as dose 1, single (Lot number: 1808978), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. The following information was reported: COVID-19 (medically significant) with onset 2022, outcome "unknown", described as "COVID 19 Treatment"; DRUG INEFFECTIVE (medically significant) with onset 2022, outcome "unknown", described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid, treatment start date: 18May2022, treatment stop date: 16May2022.  No follow-up attempts are possible. No further information is expected.
Day of  vaccination: He states he felt weak legged leaving and then in car felt lightheaded and tingling in tongue so his mom called us . He was alert and talking but pale when i found him. We asisted him to rm 2 and vs were stable bp 122/70 . He was given water, benadryl , candy bar and after about 30 mins felt better and was released with repeat stable vitals. He was told to take another benadryl in 6 hrs and to dcall or go to er if allergic reaction occurred as discussed. phone call this evening - patient doing well  Day after vaccination:  He says his shoulder is very tender and hurts to move. Jostling causes pain in his shoulder. he is able to move his arm. the shot is in a good location in the deltoid. starting on Naprosyn 500 mg BID for 7 days.
Patient said his neck felt itchy about 20 minutes after getting the vaccine. He said it was topical and localized. No problem breathing/swelling/shortness of breath. Said the itching was not internal, just externally. Gave him 25mg benadryl liquid. It did not change the itching but it also did not get any worse. Patient waited 30 minutes with no increase in symptoms and said he felt fine to go home.
At 4:00 PM noted inside of lips felt bumpy. Later tongue felt weird and looked in mirror and saw red lines on sides of my tongues. Lips burned. Later sides of tongue bumpy.
I received my vaccine at 8pm and stayed  for 15 mnutes after.  Drove home and went about my day.  Around 11pm I noticed that my legs were feeling tired.  I layed down but got up around 1:25 am. As I was making up the bed for my granddaughter I fainted without any warning other than my legs still feeling tired.  I could hear myself hitting something but could not stop it. Not sure how long I was out but I came too after hearing my granddaughter calling me, crying and asking if I was OK.  I got up from the floor and sat on the otttoman that I think broke my fall.  I told my grandson and husband. I sent my doctor a message to let her know what happened and also because my blood pressure had dropped low.
if i had my 1st dose on 7/28/21 can I still get my second dose within the next few days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (if i had my 1st dose on 7/28/21 can I still get my second dose within the next few days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (if i had my 1st dose on 7/28/21 can I still get my second dose within the next few days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (if i had my 1st dose on 7/28/21 can I still get my second dose within the next few days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant drugs were reported.  No Treatment information  were reported.
mild reaction, chills; tiredness; This case was reported by a consumer via media and described the occurrence of chills in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced chills and tiredness. On an unknown date, the outcome of the chills and tiredness were unknown.   It was unknown if the reporter considered the chills and tiredness to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received Shingles vaccine and had mild reaction (chills and tiredness). This case was linked with he case US2021AMR249129, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR249129:same reporter
Pt recv vax series'82; post vax pt exp neg Hib antibody/pt recv vax series'83; post vax exp neg Hib antibody/recv vax series'85;exp neg Hib antibody,venous stasis, fatty liver, depression, petechia, purpura,fatigue,weight inc;dx=lupus, rt a
Warmth noted down left arm  extending from  injection site; Redness noted down left arm extending from injection site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of FEELING HOT (Warmth noted down left arm  extending from  injection site) and ERYTHEMA (Redness noted down left arm extending from injection site) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 300042698) for COVID-19 vaccination.     Concurrent medical conditions included Depression, Anxiety and Birth control. Concomitant products included QUETIAPINE FUMARATE (SEROQUEL) and CLONAZEPAM for Anxiety, DESOGESTREL, ETHINYLESTRADIOL (MIRVALA 21) for Birth control, BUPROPION HYDROCHLORIDE (WELLBUTRIN) for Depression.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced FEELING HOT (Warmth noted down left arm  extending from  injection site) and ERYTHEMA (Redness noted down left arm extending from injection site). On 27-Jan-2021, FEELING HOT (Warmth noted down left arm  extending from  injection site) and ERYTHEMA (Redness noted down left arm extending from injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: New event added, concomitant medication added, reporter details updated and medical history details updated.
Initial prenatal visit on 2/4/2021, pregnancy measuring 6 weeks with visible cardiac activity. Vaccine received 2/9/2021. Repeat ultrasound 2/18/2021, no cardiac activity seen, pregnancy still measuring 6 weeks. D&C procedure on 2/23/2021 for missed abortion.
A physician reported that an infant rec'd Prevnar, Hib-Titer, and Acel-Imune vaccines on 1/31/01. That day, she developed urticaria.
Pt felt dizzy after standing up from a chair and then fainted. Went to bed shortly after and felt better the next day. No prior h/o fainting in pt. No recent illnesses.
Information has been received regarding a case in litigation for ZOSTAVAX (case # 1407USA011162) from a lawyer regarding an unspecified number of patients (demographics not provided). On unknown dates, "people of all ages ranging from 20 to 60 years old" were vaccinated with ZOSTAVAX (dosage and route of administration not provided). The outcome of the event was not provided. Additional information is not expected.
p/vax pt seen w/3day history of redness/swelling anterior rt thigh @ shot site;measured 10x15cm, sl swollen-no fever or assoc limp ? itchy-sl uncomfortable w/sleep;
Information has been received from a physician concerning a female who on 10-JAN-2007 was vaccinated with Gardasil (Lot # 655617/1447F). There was no concomitant medication. It was reported that after receiving the vaccination she was not feeling well and one month after vaccination she was diagnosed with lymphoma (onset reported as January 2007). Patient has received chemotherapy and radiation. The patient's lymphoma persisted. Lymphoma was considered to be immediately life-threatening. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of an agency and released by the regulatory agency. Additional information has been requested. 4/22/08-records received for 2/9/07-2/6/08-First seen on 2/9/07--HX of not feeling well  for approximately 1 1/2 months and a one month history of intermittent fever, chills, easy fatigability, cough and occasional night sweats. 4/29/08-DC Summary received for DOS 2/9-2/16/07-DC DX: Hodgkin Lymphoma. 2 month history of intermittent fevers to 102, chills and night sweats.
Arm was sore; Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) and PAIN IN EXTREMITY (Arm was sore) in a 25-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (2 DRINKS/WEEK.) and Forceps delivery (Started out as a normal delivery and towards the end, it was a Forceps delivery.) on 26-Jan-2020. Concurrent medical conditions included Subchorionic hemorrhage (Last Monday 25MAR2021 had some bleeding and found out it was sub chorionic hemorrhage. Bleeding in another part of the ureters where baby is not.) on 25-Mar-2021 and Anxiety (STABLE.) since 01-Jan-2020. Concomitant products included FLUOXETINE for Anxiety, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 15-Nov-2021. On 12-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 12-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm was sore) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Pregnancy test: Positive. In 2021, Ultrasound scan: Sub chorionic hemorrhage.. On an unknown date, Laboratory test: (normal) All prenatal lab and blood work, it was all normal..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-060711 (Patient Link).
On the 17th (10 days after shot) I started experiencing hives accompanied by a low grade fever. By the third day I was having swollen face and hands. By today (Dec 30th) my body is still itchy and having hives sporadically especially when pressure is applied on the skin.  The fever and muscle aches have gone.
overwhelming fatigue; bottom lip numb; right side of face numb; tip of fingers on both hands numb and tingling sensations; overall feeling of unwellnes.
Headache, Myalgia, Fever, NauseaVomiting, chills, Narrative:  N/A
Information has been received from the authors in a published literature article concerning a child patient who on an unspecified date was vaccinated with the three doses of ROTATEQ. On an unknown date, the patient experienced rotavirus and was hospitalized. At the time of the report the outcome of the patient was not reported. The article also discussed the experience of another child patients while on therapy with ROTATEQ (WAES # 1108USA01482, WAES # 1108USA02151, WAES # 1108USA02152, WAES # 1108USA02153 and WAES # 1108USA02154). Additional information has been requested.
Information has been received from a nurse, concerning her daughter, a 17 year old female (relevant medical history unspecified), who in 2010 ("last year") was vaccinated with the second dose of GARDASIL (lot #, route and injection site not reported). There were no other vaccinations or concomitant medications at the same visit. In 2010, the day after the vaccination, the patient became paralyzed from the waist down and lost feeling in her legs. She was taken to the Emergency Room (hospital unknown). She was not admitted and 3-5 days later she recovered. Vaccination with GARDASIL was discontinued after the second dose. Paralyzed from the waist down and lost feeling in legs was considered to be significant disability or incapacity by the reporter. Additional information has been requested.